Sunshine Biopharma Inc. [SBFM] Stock trading around $4.01 per share: What’s Next?


Sunshine Biopharma Inc. [NASDAQ: SBFM] stock went on an upward path that rose over 20.42% on Monday, amounting to a one-week price increase of more than 15.90%. The company report on April 25, 2022 that Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has filed a provisional patent application in the United States covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture. The patent application contains composition and utility subject matter pertaining to the structure and sequence of the relevant mRNA molecules.

The cytotoxic effects of the subject mRNA molecules were tested on different cancer cells including multidrug resistant breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2). In contrast to cancer cells, the mRNA molecules had little cytotoxic effects on non-transformed (normal) human cells (HMEC cells). These mRNA molecules are readily adaptable for delivery into patients using the mRNA vaccine technology.

Over the last 12 months, SBFM stock dropped by -85.15%.

The market cap for the stock reached $33.48 million, with 2.61 million shares outstanding and 2.25 million shares in the current float. Compared to the average trading volume of 10.12M shares, SBFM stock reached a trading volume of 49148640 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Sunshine Biopharma Inc. [SBFM]:

The Average True Range (ATR) for Sunshine Biopharma Inc. is set at 1.10, with the Price to Sales ratio for SBFM stock in the period of the last 12 months amounting to 167.42. The Price to Book ratio for the last quarter was 100.25, with the Price to Cash per share for the same quarter was set at 0.24.

SBFM Stock Performance Analysis:

Sunshine Biopharma Inc. [SBFM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.90. With this latest performance, SBFM shares gained by 37.80% in over the last four-week period, additionally sinking by -79.95% over the last 6 months – not to mention a drop of -85.15% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SBFM stock in for the last two-week period is set at 49.80, with the RSI for the last a single of trading hit 49.80, and the three-weeks RSI is set at 48.84 for Sunshine Biopharma Inc. [SBFM]. The present Moving Average for the last 50 days of trading for this stock 3.41, while it was recorded at 3.75 for the last single week of trading, and 14.25 for the last 200 days.

Insight into Sunshine Biopharma Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Sunshine Biopharma Inc. [SBFM] shares currently have an operating margin of -1068.24 and a Gross Margin at +42.84. Sunshine Biopharma Inc.’s Net Margin is presently recorded at -5444.41.

Sunshine Biopharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 22.90 and a Current Ratio set at 24.10.

Sunshine Biopharma Inc. [SBFM] Insider Position Details

1 institutional holders increased their position in Sunshine Biopharma Inc. [NASDAQ:SBFM] by around 1,463 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 1,463 shares, according to the latest SEC report filing. SBFM stock had 1 new institutional investments in for a total of 1,463 shares, while 0 institutional investors sold positions of 0 shares during the same period.